80 related articles for article (PubMed ID: 7869736)
1. Defective escape mutants of HIV.
Berry RM; Nowak MA
J Theor Biol; 1994 Dec; 171(4):387-95. PubMed ID: 7869736
[TBL] [Abstract][Full Text] [Related]
2. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
[TBL] [Abstract][Full Text] [Related]
4. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
Gorelick RJ; Gagliardi TD; Bosche WJ; Wiltrout TA; Coren LV; Chabot DJ; Lifson JD; Henderson LE; Arthur LO
Virology; 1999 Mar; 256(1):92-104. PubMed ID: 10087230
[TBL] [Abstract][Full Text] [Related]
5. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
Gorelick RJ; Benveniste RE; Gagliardi TD; Wiltrout TA; Busch LK; Bosche WJ; Coren LV; Lifson JD; Bradley PJ; Henderson LE; Arthur LO
Virology; 1999 Jan; 253(2):259-70. PubMed ID: 9918884
[TBL] [Abstract][Full Text] [Related]
6. The potential of various HIV-1 mutants to inhibit the replication of wild-type virus.
Inubushi R; Shimano R; Oshima Y; Adachi A
Biochem Biophys Res Commun; 1998 Jun; 247(2):349-52. PubMed ID: 9642129
[TBL] [Abstract][Full Text] [Related]
7. A condition for successful escape of a mutant after primary HIV infection.
Monteiro LH; Gonçalves CH; Piqueira JR
J Theor Biol; 2000 Apr; 203(4):399-406. PubMed ID: 10736216
[TBL] [Abstract][Full Text] [Related]
8. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
[TBL] [Abstract][Full Text] [Related]
9. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
[TBL] [Abstract][Full Text] [Related]
10. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
Kent SJ; Fernandez CS; Dale CJ; Davenport MP
Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of macrophage and T cell infection by HIV.
Wodarz D; Lloyd AL; Jansen VA; Nowak MA
J Theor Biol; 1999 Jan; 196(1):101-13. PubMed ID: 9892559
[TBL] [Abstract][Full Text] [Related]
12. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
13. Defective deletion mutant amplification.
McLeod B; Burroughs N
J Theor Biol; 2000 Oct; 206(4):449-64. PubMed ID: 11013108
[TBL] [Abstract][Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
15. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
Liu Y; Mullins JI; Mittler JE
Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T
J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836
[TBL] [Abstract][Full Text] [Related]
17. Cornering HIV: taking advantage of interactions between selective pressures.
Avila-Ríos S; Reyes-Terán G; Espinosa E
Med Hypotheses; 2007; 69(2):422-31. PubMed ID: 17280799
[TBL] [Abstract][Full Text] [Related]
18. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
[TBL] [Abstract][Full Text] [Related]
19. Modeling within-host evolution of HIV: mutation, competition and strain replacement.
Ball CL; Gilchrist MA; Coombs D
Bull Math Biol; 2007 Oct; 69(7):2361-85. PubMed ID: 17554585
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.
Kilby JM
Clin Infect Dis; 2001 Sep; 33(6):873-84. PubMed ID: 11512093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
